Last Updated: June 24, 2026

Suppliers and packagers for NICORETTE


✉ Email this page to a colleague

« Back to Dashboard


NICORETTE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Haleon Us Holdings NICORETTE nicotine polacrilex GUM, CHEWING;BUCCAL 018612 NDA Haleon US Holdings LLC 0135-0157-07 1 BLISTER PACK in 1 CARTON (0135-0157-07) / 110 GUM, CHEWING in 1 BLISTER PACK 2009-06-29
Haleon Us Holdings NICORETTE nicotine polacrilex GUM, CHEWING;BUCCAL 018612 NDA Haleon US Holdings LLC 0135-0157-10 1 BLISTER PACK in 1 CARTON (0135-0157-10) / 170 GUM, CHEWING in 1 BLISTER PACK 2009-06-29
Haleon Us Holdings NICORETTE nicotine polacrilex GUM, CHEWING;BUCCAL 018612 NDA Haleon US Holdings LLC 0135-0157-11 1 BLISTER PACK in 1 CARTON (0135-0157-11) / 200 GUM, CHEWING in 1 BLISTER PACK 2009-06-29
Haleon Us Holdings NICORETTE nicotine polacrilex GUM, CHEWING;BUCCAL 018612 NDA Haleon US Holdings LLC 0135-0229-05 1 BLISTER PACK in 1 CARTON (0135-0229-05) / 170 GUM, CHEWING in 1 BLISTER PACK 2009-06-29
Haleon Us Holdings NICORETTE nicotine polacrilex GUM, CHEWING;BUCCAL 018612 NDA Haleon US Holdings LLC 0135-0241-02 1 BLISTER PACK in 1 CARTON (0135-0241-02) / 100 GUM, CHEWING in 1 BLISTER PACK 2009-09-14
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Nicorette suppliers: who manufactures, supplies, and distributes nicotine replacement therapy in the US and UK

Last updated: May 26, 2026

Nicorette is a brand of nicotine replacement therapy (NRT). The brand’s “supplier” landscape is split by (1) marketing authorization holder and brand owner activity, (2) manufacturing site(s) behind each dosage form (gum, lozenge, patch, spray, inhalator in some markets), and (3) distributor roles that appear in customs, wholesaler, pharmacy supply chains, and tenders. Key suppliers vary by country and dosage form, and “Nicorette” is often supplied through local distributors rather than a single global manufacturer.

Who supplies Nicorette nicotine replacement therapy in the US?

Answer: In the US, “Nicorette” supply chains are typically executed through the local marketing authorization and its contracted manufacturers and wholesalers. The most reliable way to identify the actual manufacturing supplier is the labeler/distributor and the listed manufacturer on the specific NDC entry for each form (gum, lozenge, patch, etc.).

How to identify the actual Nicorette supplier for each NDC

For US products, supplier mapping is executed at the NDC level:

  • Labeler (distributor/market-facing supplier): appears as the “labeler” on the NDC directory entry.
  • Manufacturer / packager: appears as the “manufacturer name” on the NDC entry and the product label.
  • Dosage form differences: gum vs lozenge vs patch can list different manufacturing sites.

What suppliers appear on Nicorette gum vs lozenge vs patch

US Nicorette listings commonly split by:

  • gum manufacturer(s) and packager(s)
  • lozenge manufacturer(s) and packager(s)
  • patch manufacturer(s) and packager(s)

To determine which entities supply each, you must crosswalk:

  • NDC number → labeler/manufacturer names for that dosage form
  • labeler distribution role → contracted manufacturing site(s)

Who supplies Nicorette in the UK and EU?

Answer: In the UK and EU, Nicorette is supplied through marketing authorization holder arrangements plus local wholesalers. As with the US, each dosage form can map to different manufacturing sites.

Which entities typically sit in the UK supply chain

For UK/EU supply chain identification, the practical hierarchy is:

  • marketing authorization holder (MAH) for the specific product
  • manufacturer listed on the UK/EU leaflet/summary and product labeling
  • wholesaler/distributor shown in logistics and pharmacy channel records

How do dosage forms change suppliers

  • Different Nicorette forms can have different manufacturing plants even when the brand and MAH are shared.
  • “Supply” often shifts with batch manufacturing schedules, contract manufacturing availability, and regulatory batch release sites.

What are the major Nicorette dosage forms and do they have different suppliers?

Answer: Yes. Nicorette gum and lozenge can have different manufacturers than patches, and some markets add spray/inhalator formats. Supplier identity is usually dosage-form specific.

Dosage form mapping (what to check for supplier identity)

  • Nicotine gum: supplier identity is embedded in the NDC/label for that strength.
  • Nicotine lozenge: supplier identity is embedded in the NDC/label for that strength.
  • Nicotine patch: supplier identity is embedded in the NDC/label for that patch strength.
  • Spray/inhalator (where sold): supplier identity depends on that product’s local MAH and manufacturing label.

Which companies manufacture Nicorette nicotine replacement therapy?

Answer: Nicorette is historically associated with major global consumer and pharmaceutical nicotine suppliers, but the manufacturing company for each specific Nicorette SKU depends on the labeled manufacturer on the product pack and the NDC/marketing authorization listing.

How supplier identification should be performed for diligence

A supplier diligence workflow maps:

  1. Brand SKU (dosage form + strength)
  2. Regulatory product identifiers
    • US: NDC
    • UK/EU: product name/MA number or submission identifiers
  3. Labeled manufacturer (pack label and regulatory listing)
  4. Site location (often the manufacturing establishment)
  5. Distributor/labeler (market-facing supplier)

Does Nicorette have contract manufacturing across multiple sites?

Answer: Yes, across most branded OTC/NRT products, manufacturing is commonly split across multiple sites to support volume and regional batch release.

Evidence patterns used in OTC NRT supplier mapping

  • Different NDCs for the same dosage form show different labelers/manufacturers.
  • Different strengths often map to different packagers.
  • Batch release and distribution can rotate based on supply continuity.

What distributors supply Nicorette to pharmacies and wholesalers?

Answer: Distributors vary by market and channel. In practice, “supplier” at point of sale is often a wholesaler/distributor, while the “manufacturer” is the contract manufacturing entity listed on the label.

Channel mapping

  • retail pharmacy channel: typically via national/regional pharmaceutical wholesalers
  • hospital/clinic tenders: via tendered pharmaceutical distribution contracts
  • online pharmacy: often via the same wholesaler network plus fulfillment partners

What regulatory listings identify Nicorette suppliers?

Answer: For traceability, use the regulatory product listing that includes the labeled manufacturer and marketing authorization details.

US regulatory sources used for supplier verification

  • NDC directory (labeler and manufacturer)
  • product label/package inserts for manufacturer name and address

UK regulatory sources used for supplier verification

  • UK product listing under the relevant regulatory framework
  • patient leaflet and product label for manufacturer and MAH identity

What is the Orange Book status of Nicorette?

Answer: Nicorette is nicotine replacement therapy and is not typically maintained as a prescription drug with an Orange Book exclusivity/patent listing profile in the same way as FDA-approved prescription drugs.

Are there generic or parallel-supply competitors, and does that affect suppliers?

Answer: Supplier competition increases in markets where Nicorette is not the only NRT brand. However, “supplier” for Nicorette itself usually remains tied to the branded manufacturer and MAH arrangements.

Competitive landscape implications

  • generics and “store brand” NRT can introduce price pressure
  • supplier portfolios for contract manufacturers can rotate between brand and generic NRT lines
  • continuity of supply depends more on manufacturing capacity than on IP barriers for OTC NRT

Key takeaway on “Nicorette suppliers”

  1. Supplier identity is SKU-specific (dosage form, strength).
  2. In the US, the most operational supplier mapping is NDC labeler/manufacturer.
  3. In the UK/EU, supplier mapping follows MAH plus labeled manufacturer on the product.

Key Takeaways

  • Nicorette supplier lists are not one-company static. They change by dosage form and strength.
  • The authoritative way to name suppliers is from product labeling and regulatory listings (US: NDC labeler/manufacturer; UK/EU: product MA/label).
  • Distribution to pharmacies is usually handled by wholesalers, which are different from the manufacturer.

FAQs

1) How can I tell the manufacturer of Nicorette gum vs Nicorette lozenges?
Use the labeled manufacturer name on the pack and the NDC directory entry for each specific strength.

2) Do Nicorette patch and Nicorette gum come from the same supplier?
Not necessarily. They can be manufactured or packaged by different labeled manufacturers depending on the SKU.

3) Who is the “labeler” for Nicorette on the NDC?
The labeler is the market-facing entity listed in the NDC entry for that specific product.

4) Is Nicorette covered by FDA Orange Book patents?
Nicotine replacement products like Nicorette typically do not have the same Orange Book patent listing profile as prescription drugs, though the exact status depends on whether any associated FDA product is listed under an application.

5) Do Nicorette suppliers change across batches or shortage periods?
They can. Contract manufacturing and packager assignments can rotate to maintain supply, which shows up as different labeled manufacturers or packagers on specific SKUs.


References (APA)

  1. FDA. (n.d.). National Drug Code (NDC) Directory. U.S. Food and Drug Administration.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.